Insulin-dependent diabetes mellitus: Islet changes in relation to etiology and pathogenesis

Endocrine Pathology

Volumn 8, Issue 4, 1997, Pages 273-282

  Klöppel, Günter ^a   Clemens, Andreas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Immunopathogenesis; Insulin dependent diabetes; Islet changes

Indexed keywords

EID: 0003737606     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739929     Document Type: Review

References (69)

1. Püschel K, Lockemann U, Saukko P, Klöppel G, Eisenmenger W. Scharlatanerie mit tödlichem Ausgang. Münch Med Wochenschr 138:287-290, 1996.
2. WHO Expert Committee on Diabetes Mellitus. 2nd report. Technical report series. 1980.
3. Zimmet P. Type 2 (non-insulin dependent) diabetes: an epidemiological overview. Diabetologia 22:399-411, 1982.
4. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633, 1965.
5. Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456-461, 1984.
6. Klöppel G, Drenck CR, Oberholzer M, Heitz PU. Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch [A] Pathol Anat 403:441-452, 1984.
7. LeCompte PM. "Insulitis" in early juvenile diabetes. Arch Pathol 66:450-457, 1958.
8. MacLean N, Ogilvie RF. Observations on the pancreatic islet tissue of young diabetic subjects. Diabetes 8:83-91, 1953.
9. Löhr M, Klöppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757-762, 1987.
10. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371, 1983.
11. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 22:158-167, 1981.
12. Korc M, Owerbach D, Quinto C, Rutter WJ. Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin. Science 213:351-353, 1981.
13. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267-274, 1986.
14. Lernmark Å, Klöppel G, Stenger D, Vathanaprida C, Fält K, Landin-Olsson M, Baskin DG, Palmer JP, Gown AM, Petersen JS, Li L, Edenvall H, Mauseth RS. Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 425:631-640, 1995.
15. von Meyenburg H. Über "Insulitis" bei Diabetes. Schweiz Med Wochenschr 21:554-557, 1940.
16. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353-360, 1985.
17. Hanninen A, Jalkanen S, Salmi M, Tolkkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:1901-1910, 1992.
18. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriguez-Rilo H, Finegold D, Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355, 1994.
19. Susman W. Atrophy of the adrenals associated with Addison's disease. J Pathol Bacteriol 33:749-760, 1930.
20. Masi AT, Hartmann WH, Hahn BN, Abbey H, Shulmarn LE. Hashimoto's disease: a clinicopathological study with matched controls. Lancel i:123-126, 1965.
21. Foulis AK, Jackson R, Farquharson MA. The pancreas in idiopathic Addison's disease: a search for a prediabetic pancreas. Histopathology 12:481-490, 1988.
22. Löhr M, Schmitt P, Klöppel G. Inselveränderungen beim Insulin-abhängigen Diabetes im Alter. Immunzytochemische Pankreasuntersuchungen bei einer diabetischen Patientin mit Hypothyreose. Pathologe 9:103-108, 1988.
23. Handwerger BS, Fernandes G, Brown DM. Immune and autoimmune aspects of diabetes mellitus. Hum Pathol 11:338-352, 1980.
24. Junker K, Egeberg J, Kromann H, Nerup J. An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand 85:699-706, 1977.
25. Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, Unger RH. Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci USA 73:1338-1342, 1976.
26. Gepts W, De Mey J. Islet cell survival determined by morphology: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl.1):251-261, 1978.
27. Ogilvie RF. The endocrine pancreas in human and experimental diabetes. In: Cameron MP, O'Connor M, eds. Ciba Foundation Colloquia on Endocrinology. The aetiology of diabetes mellitus and its complications. London: Churchill Livingstone, 1964; pp. 49-74.
28. Atkinson MA, Bowman MA, Kuo-Jang K, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 329: 1853-1858, 1993.
29. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994.
30. Gorsuch AN, Lister J, Dean BM, Spencer KM, McNally JM, Bottazzo GF, Cudworth AG. Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet ii:1363-1365, 1981.
31. r 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79:826-934, 1987.
32. Lernmark A. Islet cell antibodies. Diabet Med 4:285-292, 1987.
33. r autoantibodies as predictors of insulin-dependent diabetes. Lancet 335:1357-1360, 1990.
34. Wilkin TJ. Insulin autoantibodies as markers for type I diabetes. Endocr Rev 11:92-104, 1990.
35. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, Karlsen AK, Boel E, Hagopian WA, Hejnaes KR, Moody A, Dyrberg T, Lernmark A, Madsen OD, Michielsen BK. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42:484-495, 1993.
36. Aguilar-Diosdado M, Parkinson D, Corbett JA, Kwon G, Marshall CA, Gingerich RL, Santiago JV, McDaniel ML. Potential autoantigens in IDDM: expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the β-cell surface. Diabetes 43:418-425, 1994.
37. Sibley RK, Sutherland DER, Goetz FC, Michael AF. Recurrent diabetes mellitus in the pancreatic iso- and allograft period: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985.
38. Tydén G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 335:860-863, 1996.
39. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243-1244, 1993.
40. Klöppel G. Experimental insulitis. In: Volk BW, Arquilla ER, Allen R, eds. The diabetic pancreas. New York: Plenum; 1985; pp. 467-492.
41. Griffin AC, Zhao W, Wegmann KW, Hickey WF. Experimental autoimmune insulitis: induction by T lymphocytes specific for a peptide of proinsulin. Am J Pathol 147:845-857, 1995.
42. Ohashi PS, Oehen S, Bürki K, Pircher HP, Ohashi CT, Odermatt B, Malissen B, Zinkernagel R, Hengartner H. Ablation of "tolerance" ancl induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305, 1991.
43. Like AA, Weringer EJ. Autoimmune diabetes in the Bio Breeding/Worcester rat. In: Lefèbvre P, Pipeleers DG, eds. The pathology of the endocrine pancreas in diabetes. Berlin: Springer, 1988; pp 269-284.
44. Kolb H. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab Rev 3:751-778, 1987.
45. Castano L, Eisenbarth G. Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647-679, 1990.
46. Itoh N, Hanafusa T, Yamagata K, Nakajima H, Tomita K, Tamura S, Inada M, Kawata M, Kono N, Kuwajima M, Matsuzawa Y. No detectable cytomegalovirus and Epstein-Barr virus genomes in the pancreas of recent-onset IDDM patients. Diabetologia 38:667-671, 1995.
47. Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 40:53-61, 1997.
48. Nuovo JA, Baker JR, Wartofsky L, Lukes YG, Burman KD. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 37:317-320, 1988.
49. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, Savilahti E, Åkerblom HK, Dosch HM. A bovine albumine peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327:302-307, 1992.
50. Bottazzo GF, Pujol-Borrell R, Hanafusa T. Hypothesis: role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet ii:1115-1119, 1983.
51. Foulis AK, Farquharson MA. Aberrant expression of HLA-DR antigens by insulin-containing B-cells in recent-onset type 1 diabetes mellitus. Diabetes 35:1215-1224, 1986.
52. Madsbad S. Prevalence of residual β cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes. Diabetologia 24:141-147, 1983.
53. Cudworth AG, Festenstein H. HLA genetic heterogeneity in diabetes mellitus. Br Med Bull 34:285-289, 1978.
54. Wolf E, Spencer KM, Cudworth AG. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24:224-230, 1983.
55. Rossini AA, Mordes JP, Handler ES. Perspectives in diabetes: speculations on etiology of diabetes mellitus. Tumbler hypothesis. Diabetes 37:257-261, 1988.
56. Barnett AH, Epp C, Leslie RDG, Pyke DA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87-93, 1981.
57. Bärmeier H, McCulloch DK, Neifing JL, Warnock G, Rajotte RV, Palmer JP, Lernmark Å. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia 34:727-733, 1991.
58. Rayfield EJ, Yoon IW. Role of viruses in diabetes. In: Cooperstein SJ, Watkins D, eds. The islets of Langerhans. New York: Academic, 1981; pp 427-451.
59. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses: some recent developments. Diabetologia 36:687-695, 1993.
60. Kobayashi T, Nakanishi K, Kaijo H, Morinaga S, Sugimoto T, Murase T, Kosaka K. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:363-370, 1990.
61. Gladisch R, Hofmann W, Waldherr RI. Myokarditis und Insulins nach Coxsackie-Virus-Infektion. Zeitschr Kardiol 65:849-855, 1976.
62. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173-1179, 1979.
63. Gorsuch AN, Spencer KM, Lister J, Wolf E, Bottazzo GF, Cudworth AG. Can future type 1 diabetes be predicted? A study in families of affected children. Diabetes 31:862-866, 1982.
64. Millward BA, Alviggi L, Hoskins PJ, Johnston C, Heaton D, Bottazzo GF, Vergani D, Leslie RDG, Pyke DA. Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins. Br Med J 292:793-796, 1986.
65. Gleichmann H, Zürcher B, Greulich B, Gries FA, Henrichs HR, Bertrams J, Kolb H. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes in adults. Diabetologia 27:90-92, 1984.
66. Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF. Organ-specific autoimmunity and HLA-DR antigens as markers for B-cell destruction in patients with type II diabetes. Diabetes 37:99-103, 1988.
67. Doniach D, Bottazzo GF. Autoimmunity and the endocrine pancreas. Pathol Annu 7:327-346, 1977.
68. Ludvigsson J, Samuelsson U, Beauforts C, Deschamps I, Dorchy H, Drash A, Francois R, Herz G, New M, Schober E. HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29:207-210, 1986.
69. Wagner R, McNally JM, Bonifacio E, Genovese S, Foulis A, McGill M, Christie MR, Betterle C, Bosi E, Bottazzo GF. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with B-selective GAD-specific islet cell antibodies. Diabetes 43:851-856, 1994.